This article explores the 14 most expensive stocks insiders are buying in March. Previously, we covered the 15 stocks receiving the most insider investment in March.
President Donald Trump is preparing to announce “Liberation Day” tariffs on April 2, introducing so-called reciprocal tariffs as retaliation for tariffs imposed by other countries. While the announcement would represent a significant expansion of U.S. tariffs, experts familiar with the matter indicate it is expected to be more targeted than the broad, global approach, writes Bloomberg.
The stock market is reacting to these reports with the broader market gaining 1.5%, blue-chip companies advancing around 1.2% and the NASDAQ Composite being up more than 2%.
As investors digest daily developments, uncertainty continues to weigh on the market. During such times, insider trading often draws attention, as executive stock purchases may signal confidence in a company’s future. However, insider selling doesn’t always indicate doubt—it could reflect personal financial needs or diversification strategies. Executives often use pre-set plans like 10b5-1 to ensure transparency. While insider trading offers valuable clues, it should be considered alongside financial health, market trends, and industry shifts.
A fast-paced trading floor with brokers in motion with the Hong Kong stock exchange in the backdrop.
Which stocks are insiders buying at the highest prices this month? To find out, we used Insider Monkey’s insider trading stock screener, focusing only on stocks where at least two insiders had purchased shares in March. From there, we ranked the 14 stocks with the highest average price per share.
Our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds, focusing on insider trading and stock picks from hedge fund investor newsletters and conferences. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
With each stock, we note the average price per share of these purchases and the stock’s market capitalization. Let’s take a look at the 14 most expensive stocks insiders are buying in March.
14. Celanese Corporation (NYSE:CE)
Market Capitalization: $6.46 billion
We start this list of 14 most expensive stocks insiders are buying in March with Celanese Corporation, a chemicals company serving industrial customers. Celanese is a leading global producer of acetic acid and vinyl acetate monomer. Formerly known as Hoechst Celanese, the Irving, Texas-based company operates 25 production plants and six research centers across 11 countries, primarily in North America, Europe, and Asia.
For the full year 2024, Celanese reported a U.S. GAAP diluted loss per share of $13.86 and adjusted earnings per share of $8.37. The company generated $10.3 billion in net sales, marking a 6% decline from the previous year.
In March, four insiders acquired approximately $697,468 worth of Celanese shares at an average price of $54.27 per share. Currently, the stock trades at $59.34 per share, having declined 14.26% year-to-date and 64.63% over the past 12 months.
According to StockAnalysis, 16 analysts have given Celanese stock an average rating of “Hold”. The 12-month price forecast for the stock is $71.44, suggesting a 20.25% increase from the latest price.
13. Greif, Inc. (NYSE:GEF)
Market Capitalization: $2.66 billion
Greif manufactures and sells industrial packaging products and services globally, including steel, fiber, and plastic drums, rigid containers, and closure systems. The Delaware, Ohio-based company also produces corrugated products, recycled paperboard, adhesives, and offers container lifecycle management, logistics, and warehousing services. Founded in 1877, Greif serves industries such as packaging, automotive, food, and building products.
For the first quarter of fiscal 2025, Greif reported a net income of $8.6 million or $0.15 per diluted Class A share, compared to net income of $67.2 million, or $1.17 per diluted Class A share in the prior year. Adjusted EBITDA increased 5.9% to $145.1 million compared to adjusted EBITDA of $137.0 million in the previous fiscal year. Total debt of $2.84 billion increased by $548.4 million, primarily as a result of the acquisition of Ipackchem.
In March, two insiders acquired approximately $404,801 worth of Greif shares at an average price of $58.37 per share. Year-to-date, the stock is down by 10.09% trading at $54.37 per share. Over the past 12 months, Greif shares have dropped 17.71%.
The average rating on the stock from five Wall Street analysts is “Moderate Buy.” The analysts have also set a 12-month price target of $73.60, which is an increase of 33.90% from the latest price, according to TipRanks.
